Alessa Therapeutics, Inc.
PrivateLast Round
VC Round
May 1, 2025
Total Funding Raised
$18.35M
Company Overview
Alessa Therapeutics, Inc. is a biotechnology company that develops proprietary localized drug delivery technology for the early interception and treatment of prostate cancer and other solid organ diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alessa Therapeutics, Inc. Comparables
Compare Alessa Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PanTher Therapeutics | 85% | |
| Postsurgical Therapeutics, Inc. | 80% | |
| NanOlogy, LLC | 79% | |
Alessa Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | May 1, 2025 | ||||
| Seed | Dec 12, 2024 | ||||
| Grant | Aug 4, 2021 | ||||
| Seed | Mar 21, 2019 |
Key People
Founding team and executive leadership
Alessa Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| BioInnovation Capital | Seed |
| Mission BioCapital | VC Round, Seed |
| Cure Ventures | VC Round |
| Johnson & Johnson Innovation – JJDC | Seed |
| Johnson & Johnson Innovation - JJDC, Inc. | Seed |
| Mission Bay Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2026
Will present at the 44th Annual J.P. Morgan Healthcare Conference.
- May 1, 2025
$25.4M raised with participation from Cure Ventures and Mission BioCapital.
Alessa Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alessa Therapeutics, Inc.'s valuation, stock price, and market status.